Lysosomal Storage Disease
Infant tests for debilitating diseases set for mainstream
(Medical Xpress)—Michael Gelb and František Tureček have worked more than a decade to devise and implement newborn screening for some debilitating, often-fatal conditions that show up in the first year ...
Diseases, Conditions, Syndromes
Apr 02, 2013 |
5 / 5 (1) |
0
Experimental molecular therapy crosses blood-brain barrier to treat neurological disease
Researchers have overcome a major challenge to treating brain diseases by engineering an experimental molecular therapy that crosses the blood-brain barrier to reverse neurological lysosomal storage disease in mice.
Medical research
Feb 04, 2013 |
5 / 5 (1) |
0
|
New technology for more efficient treatment of Pompe disease, other metabolic disorders
VIB researchers from UGent and Vrije Universiteit Brussel , together with a team of the firm Oxyrane have developed a new technology that can lead to a more efficient and possibly also cheaper therapy for diseases such as ...
Medical research
Nov 19, 2012 |
not rated yet |
0
Biochemists open path to molecular 'chaperone' therapy for metabolic disease
University of Massachusetts Amherst researchers, experts in revealing molecular structure by X-ray crystallography, have identified two new small "chaperone" molecules that may be useful in treating the inherited ...
Medical research
Oct 09, 2012 |
not rated yet |
0
|
The genetic cause of a severe skeletal disease in Brazilian Terrier puppies revealed
The genetics research group led by Professor Hannes Lohi, based at the University of Helsinki and the Folkhälsan Research Center, has, in collaboration with Adjunct Professor Kirsi Sainio's research group, discovered ...
Genetics
Aug 06, 2012 |
not rated yet |
0
Parents seen as critical stakeholders in expanding newborn screening
Parents must be considered when states decide to expand genetic screening programs for newborns, according to a new study that looked at mandatory testing panels and political pressure by advocacy groups.
Pediatrics
Jun 21, 2012 |
not rated yet |
0
|
Biologists find potential drug that speeds cellular recycling
A University of Michigan cell biologist and his colleagues have identified a potential drug that speeds up trash removal from the cell's recycling center, the lysosome.
Medical research
Mar 13, 2012 |
5 / 5 (9) |
0
|
Researchers study aging's effect on the brain
(Medical Xpress) -- Research by biologists at the University of York and Hull York Medical School has revealed important new information about the way the brain is affected by age.
Neuroscience
Oct 10, 2011 |
3 / 5 (4) |
0
|
First controlled clinical trial for Juvenile Batten disease to start
After years of building hope for a treatment, Rochester researchers and clinicians will begin the first controlled clinical trial for Juvenile Batten disease this summer, thanks to $1 million in grants from the Food and Drug ...
Diseases, Conditions, Syndromes
May 31, 2011 |
not rated yet |
0
NIH grant for the move toward clinical trials targeting the lysosomal storage disease MPSIIIB
Investigators at Nationwide Children's have received a grant from the National Institutes of Health (NIH) to help move a therapy for MPS IIIB that has been shown effective in mice toward clinical trials in humans.
Medical research
May 25, 2011 |
not rated yet |
0
Lysosomal storage diseases (LSDs; /ˌlaɪsəˈsoʊməl/) are a group of approximately 50 rare inherited metabolic disorders that result from defects in lysosomal function. Lysosomal storage diseases result when the lysosome – a specific organelle in the body's cells – malfunctions.
Lysosomal storage disorders are caused by lysosomal dysfunction usually as a consequence of deficiency of a single enzyme required for the metabolism of lipids, glycoproteins (sugar containing proteins) or so-called mucopolysaccharides. Individually, LSDs occur with incidences of less than 1:100,000; however, as a group the incidence is about 1:5,000 - 1:10,000. Most of these disorders are autosomal recessively inherited such as Niemann-Pick disease, type C, however a few are X-linked recessively inherited, such as Fabry disease and Hunter syndrome (MPS II).
The lysosome is commonly referred to as the cell’s recycling center because it processes unwanted material into substances that the cell can utilize. Lysosomes break down this unwanted matter via enzymes, highly specialized proteins essential for survival. Lysosomal disorders are triggered when a particular enzyme exists in too small an amount or is missing altogether. When this happens, substances accumulate in the cell. In other words, when the lysosome doesn’t function normally, excess products destined for breakdown and recycling are stored in the cell.
Like other genetic diseases, individuals inherit lysosomal storage diseases from their parents. Although each disorder results from different gene mutations that translate into a deficiency in enzyme activity, they all share a common biochemical characteristic – all lysosomal disorders originate from an abnormal accumulation of substances inside the lysosome.
Lysosomal storage diseases affect mostly children and they often die at a young and unpredictable age, many within a few months or years of birth. Many other children die of this disease following years of suffering from various symptoms of their particular disorder.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
Latest Spotlight News
First long-term study reveals link between childhood ADHD and obesity
A new study conducted by researchers at the Child Study Center at NYU Langone Medical Center found men diagnosed as children with attention-deficit/hyperactivity disorder (ADHD) were twice as likely to be obese in a 33-year ...
Neurons that can multitask greatly enhance the brain's computational power, study finds
Over the past few decades, neuroscientists have made much progress in mapping the brain by deciphering the functions of individual neurons that perform very specific tasks, such as recognizing the location ...
Team finds mechanism linking key inflammatory marker to cancer
In a new study described in the journal Oncogene, researchers reveal how a key player in cell growth, immunity and the inflammatory response can be transformed into a primary contributor to tumor growth.
Immune protein could stop diabetes in its tracks
Melbourne researchers have identified an immune protein that has the potential to stop or reverse the development of type 1 diabetes in its early stages, before insulin-producing cells have been destroyed.
Measles surges in UK years after flawed research (Update)
More than a decade ago, British parents refused to give measles shots to at least a million children because of now discredited research that linked the vaccine to autism. Now, health officials are scrambling ...
Treatment of sleep apnea improves glucose levels in prediabetes
Optimal treatment of sleep apnea in patients with prediabetes improves blood sugar (glucose) levels and thus can reduce cardiometabolic risk, according to a study to be presented at the ATS 2013 International Conference in ...
Whole-cell vaccine was more effective than acellular vaccine during CA pertussis outbreak
Whole-cell pertussis vaccines were more effective at protecting against pertussis than acellular pertussis vaccines during a large recent outbreak, according to a new Kaiser Permanente study published in Pediatrics.
Blame your parents for bunion woes
A novel study reports that white men and women of European descent inherit common foot disorders, such as bunions (hallux valgus) and lesser toe deformities, including hammer or claw toe. Findings from the Framingham Foot ...
Vitamin D could provide new and effective treatments for asthma
(Medical Xpress)—Scientists at King's College London have discovered that Vitamin D has the potential to significantly reduce the symptoms of asthma. The study, led by Professor Catherine Hawrylowicz from ...
Research uncovers a potential role of two proteins in diabetes
(Medical Xpress)—Flinders University researchers are breaking new ground in a decade-long journey to pinpoint the function of two closely related proteins.